Bottom line Tirzepatide and semaglutide can both be effective treatments for weight loss
Regular physical activity is also vital
Osteoporos Int (2015) 26(1):20918.10.1007/s00198-014-2845-8 20 DriessenJHHenryRMvan OnzenoortHALalmohamedABurdenAMPrieto-AlhambraDet alBone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis
Regardless of these variations, a central question remains: is the muscle loss associated with GLP-1RAs therapy an adaptive or maladaptive response
When name brands face shortages, the FDA allows pharmacies to compound drugs, a process that uses the same ingredients and does not require FDA approvalthus allowing Hims & Hers to enter the market
The retrospective cohort study, published on August 11 in Over two years of follow-up, those taking a GLP-1 had higher rates of NAION and other optic nerve conditions than those in the comparison group